Related Experiment Video
Updated: Jan 22, 2026

Growth and Electrostatic/chemical Properties of Metal/LaAlO3/SrTiO3 Heterostructures
Published on: February 8, 2018
(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one inhibited osteosarcoma growth by inducing apoptosis
Ming-Zhu Song1, Feng-Lin Zhang2, Le-Jun Lin3
1Department of Orthopaedics and Traumatology, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China.
Abstract:
As one of the leading causes of cancer-associated mortalities worldwide, the overall survival rate of osteosarcoma has stably remained at 15-30% for several decades. (3R)- 5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one (TIM), isolated from the whole plant of Selaginella moellendorffii Hieron., has been reported to have pharmacological activities. In the present study, the anti-proliferative effects of TIM against osteosarcoma were evaluated, and the underlying molecular mechanisms were explored. The results demonstrated that TIM inhibited proliferation and induced apoptosis in U2OS cells. Furthermore, the expression of the pro-apoptotic protein NOXA in the intrinsic apoptosis pathway was upregulated by TIM, while the expression of myeloid cell leukemia 1, an anti-apoptotic protein, was downregulated. In addition, TIM increased the protein expression of the endoplasmic reticulum stress markers inositol-requiring enzyme 1, activating transcription factor 6 and glucose-regulated protein 78. These results suggested that TIM induced ER stress response while activating intrinsic apoptosis. Furthermore, treating osteosarcoma tumor-bearing mice with TIM significantly inhibited the tumor growth in the xenograft animal model. Overall, the study results suggested that TIM may serve as a potential antitumor agent against osteosarcoma.
Insights
The natural compound (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one (TIM) inhibits osteosarcoma cell proliferation and tumor growth. TIM activates apoptosis and endoplasmic reticulum stress, suggesting its potential as an osteosarcoma antitumor agent.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Osteosarcoma is a leading cause of cancer mortality with a poor survival rate.
- The natural compound (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one (TIM), from *Selaginella moellendorffii*, exhibits pharmacological activities.
Purpose of the Study:
- To evaluate the anti-proliferative effects of TIM on osteosarcoma.
- To elucidate the molecular mechanisms underlying TIM's action against osteosarcoma.
Main Methods:
- In vitro studies using U2OS osteosarcoma cells.
- Western blot analysis to assess protein expression.
- In vivo studies using a xenograft mouse model.
Main Results:
- TIM inhibited osteosarcoma cell proliferation and induced apoptosis.
- TIM upregulated the pro-apoptotic protein NOXA and downregulated the anti-apoptotic protein myeloid cell leukemia 1.
- TIM induced endoplasmic reticulum stress markers (IRE1, ATF6, GRP78) and inhibited tumor growth in vivo.
Conclusions:
- TIM activates intrinsic apoptosis and endoplasmic reticulum stress pathways in osteosarcoma.
- TIM demonstrates significant anti-tumor activity in osteosarcoma models.
- TIM shows potential as a novel therapeutic agent for osteosarcoma treatment.
Related Concept Videos
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Apoptosis
Feedback Inhibition
Enzyme Inhibition

